Increased vulnerability to alcohol abuse after gastric bypass: Neural mechanisms

胃绕道手术后更容易酗酒:神经机制

基本信息

  • 批准号:
    9217538
  • 负责人:
  • 金额:
    $ 18.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-02-05 至 2019-01-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Obesity and its associated health consequences are among the main causes of preventable death. At present, Roux-en-Y gastric bypass (RYGB) surgery is a commonly performed and very effective method to achieve significant, long-term weight loss and to treat associated comorbidities. However, in contrast to improved food preferences and reduced food cravings following RYGB, clinical reports have revealed a concern for patients developing an increased risk for alcohol consumption. Whereas our research group and others have recently found increased alcohol preference and intake in dietary obese male rats that received RYGB suggesting a biological etiology (i.e., not confounded by psycho-social, and co-morbidity factors specific to humans), there is no clear evidence that these effects would eventually lead to increased risk for development of alcohol addiction. In addition, the ultimate neural mechanisms underlying how RYGB may increase and sustain motivation for alcohol use and potential contributing factors (such as postoperative dietary compliance, weight loss history and hormonal/metabolic improvements) warrant investigation. Moreover, no study has yet investigated alcohol effects in female rats despite the fact that >80% of RYGB patients are women. Thus, this high-risk high-gain, proof-of-concept R21 application will use high fat diet-induced obese, non-alcohol- preferring Sprague-Dawley female rats, believed to capture the most common environmental etiology and multigenic characteristics of obesity, and a proxy for the exclusion criteria of heavy drinkers by most bariatric surgery centers. The central hypothesis at test is that RYGB increases preference for and intake of alcohol based on its increased rewarding effects, and in turn, poses an increased risk for development of addiction. Regarding the underlying mechanism, we propose that this effect is due to alleviated obesity-related deficits in the brain dopamine systems due to yet unknown unique effects of surgery, i.e., independent of weight loss or post-surgical change of diets. Aim 1 will use a comprehensive battery of behavioral tests to investigate the hypothesis that RYGB increases alcohol-seeking and -taking behaviors and results in increased vulnerability to alcohol addiction independent of weight loss and change in diet. Functional changes in brain activity after RYGB vs. caloric restriction to conditioned alcohol cues will be assessed using in-vivo brain imaging (positron emission tomography, µPET). Aim 2 will extend investigations to underlying mechanisms by testing the effects of surgery on functional and static measures of dopamine signaling, and vice versa: the effects of dopamine receptor manipulations on alcohol-related behaviors. These studies are expected to provide initial data for a future R01 application with a focus on specific pathways and pharmacological targets upstream to the dopamine reward system. This pre-clinical translational study is of high impact in that it will help clinicians to make personalized postoperative treatment plans for patients wit increased risk of alcohol use disorder and to prevent development of addiction.


项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effect of vertical sleeve gastrectomy on alcohol consumption and preferences in dietary obese rats and mice: A plausible role for altered ghrelin signaling.
  • DOI:
    10.1016/j.brainresbull.2017.08.004
  • 发表时间:
    2018-04
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Orellana ER;Jamis C;Horvath N;Hajnal A
  • 通讯作者:
    Hajnal A
Roux-en-Y gastric bypass in rat reduces mu-opioid receptor levels in brain regions associated with stress and energy regulation.
Roux-en-Y 大鼠胃绕道手术可降低与压力和能量调节相关的大脑区域的 mu-阿片受体水平。
  • DOI:
    10.1371/journal.pone.0218680
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    McGregor,Matthew;Hamilton,John;Hajnal,Andras;Thanos,PanayotisK
  • 通讯作者:
    Thanos,PanayotisK
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDRAS HAJNAL其他文献

ANDRAS HAJNAL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDRAS HAJNAL', 18)}}的其他基金

Gastric bypass surgery alters the regulation of food reward
胃绕道手术改变了食物奖励的调节
  • 批准号:
    7651742
  • 财政年份:
    2009
  • 资助金额:
    $ 18.41万
  • 项目类别:
Gastric bypass surgery alters the regulation of food reward
胃绕道手术改变了食物奖励的调节
  • 批准号:
    7777339
  • 财政年份:
    2009
  • 资助金额:
    $ 18.41万
  • 项目类别:
Gastric bypass surgery alters the regulation of food reward
胃绕道手术改变了食物奖励的调节
  • 批准号:
    7878211
  • 财政年份:
    2009
  • 资助金额:
    $ 18.41万
  • 项目类别:
Gastric bypass surgery alters the regulation of food reward
胃绕道手术改变了食物奖励的调节
  • 批准号:
    8245785
  • 财政年份:
    2009
  • 资助金额:
    $ 18.41万
  • 项目类别:
Gastric bypass surgery alters the regulation of food reward
胃绕道手术改变了食物奖励的调节
  • 批准号:
    8730361
  • 财政年份:
    2009
  • 资助金额:
    $ 18.41万
  • 项目类别:
Gastric bypass surgery alters the regulation of food reward
胃绕道手术改变了食物奖励的调节
  • 批准号:
    8053796
  • 财政年份:
    2009
  • 资助金额:
    $ 18.41万
  • 项目类别:
Dopamine mechanisms in development of type-2 diabetes
2 型糖尿病发展中的多巴胺机制
  • 批准号:
    6988503
  • 财政年份:
    2004
  • 资助金额:
    $ 18.41万
  • 项目类别:
Dopamine mechanisms in development of type-2 diabetes
2 型糖尿病发展中的多巴胺机制
  • 批准号:
    6704050
  • 财政年份:
    2004
  • 资助金额:
    $ 18.41万
  • 项目类别:
Dopamine mechanisms in development of type-2 diabetes
2 型糖尿病发展中的多巴胺机制
  • 批准号:
    7333308
  • 财政年份:
    2004
  • 资助金额:
    $ 18.41万
  • 项目类别:
Dopamine mechanisms in development of type-2 diabetes
2 型糖尿病发展中的多巴胺机制
  • 批准号:
    6835645
  • 财政年份:
    2004
  • 资助金额:
    $ 18.41万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了